The ADCC Reporter Bioassay from Promega is now available in both V158 and F158 variant formats. Use this functional, sister bioassay approach to better characterize Ab drugs with MOA directed through FcgammaRIIIa (CD16a) receptor. Not yet familiar with this novel bioassay that is becoming the industry standard? This slidedoc introduces the reporter-based ADCC technology. Contact me for any questions.